OOIR: Observatory of International Research

Papers

(The H4-Index of Diabetes-Metabolism Research and Reviews is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
	275
Longitudinal cardiovascular health measured by life's essential 8 metrics with incident diabetes: A 13‐year prospective cohort study	181
Vision Loss as a Rising Global Health Challenge: Comprehensive Analysis of High Fasting Plasma Glucose Burden and Projections to 2035	123
Charcot neuroarthropathy in persons with diabetes: It's time for a paradigm shift in our thinking	114
Issue Information	114
Central and Peripheral Sensitivity to Thyroid Hormones Correlate to Metabolically Obesity Phenotypes in Chinese Euthyroid Adults: A Cross‐Sectional Study	76
Efficacy and safety of fixed‐ratio combination insulin degludec/liraglutide in type 2 diabetes: A systematic review and meta‐analysis of randomised controlled trials	76
Cover Image	76
The role of long non‐coding RNAs in the development of diabetic kidney disease and the involved clinical application	63
Early Postpartum Metabolic Heterogeneity Among Women Who Progressed to Type 2 Diabetes After Gestational Diabetes: A Prospective Cohort	59
The circadian syndrome is a predictor for cognition impairment in middle‐aged adults: Comparison with the metabolic syndrome	58
Guidelines on the diagnosis and treatment of active Charcot neuro‐osteoarthropathy in persons with diabetes mellitus (IWGDF 2023)	57
Effects of treatment with Glucagon‐like peptide‐1 receptor agonist on prediabetes with overweight/obesity: A systematic review and meta‐analysis	57
	55
Development of a Chinese‐Specific Clinical Model to Predict Maturity‐Onset Diabetes of the Young	53
Withdrawal: Screening for people with glucose metabolism disorders within the framework of the DEMOJUAN project (DEMOnstration area for primary prevention of type 2 diabetes, JUAN Mina and Barranquill	46
Endostatin, soluble tumour necrosis factor receptor 1 and soluble tumour necrosis factor receptor 2 cannot predict new onset of microalbuminuria in patients with type 2 diabetes	45
Microbiome‐modulating nutraceuticals ameliorate dyslipidemia in type 2 diabetes: A systematic review, meta‐analysis, and meta‐regression of clinical trials	41
The relationship between neonatal hypoglycaemia and cord blood C‐peptide levels in neonates of birthing individuals with type 1 diabetes	40
Stuttering in adolescence and the risk for dysglycemia in early adulthood	38
A variation in SORBS1 is associated with type 2 diabetes and high‐density lipoprotein cholesterol in Chinese population	37
Classification of foot ulcers in people with diabetes: A systematic review	37
Predictors of change in hypoglycemia unawareness among patients with type 1 diabetes	37
	36
Prevalence and risk factors of diabetic peripheral neuropathy: A population‐based cross‐sectional study in China	36

Assessment of the spectrum of depression and bipolarity in patients with type 1 diabetes	36
	34
Sex differences in the relationship between platelet count and type 2 diabetes risk in community‐dwelling adults: Longitudinal findings over 14 years	33
Cover Image	32
Machine Learning‐Assisted Analysis of Sublingual Microcirculatory Dysfunction for Early Cardiovascular Risk Evaluation and Cardiovascular‐Kidney‐Metabolic Syndrome Stage in Patients With Type 2 Diabet	32
Fibre‐Enriched High‐Carbohydrate (FEHC) Diet Modulates Inflammation Without Affecting Bone Health in Older Women With Obesity: A Randomised Clinical Trial	32